DMII (Drugs Made In America Acquisition II) Total Liabilities: $18.17 Mil (As of Mar. 2026)


DMII Drugs Made In America Acquisition II Corp DMII
15 GF Score
Price $10.10
! 1 Warning Sign
View Full Analysis

What is Drugs Made In America Acquisition II Total Liabilities?

Drugs Made In America Acquisition II DMII 15 Total Liabilities is $18.17 Mil as of Mar. 2026. GuruFocus rates DMII with a GF Score™ of 15/100. The stock has 1 warning sign investors should review.

Drugs Made In America Acquisition II's Total Liabilities for the quarter that ended in Mar. 2026 was $18.17 Mil.

Drugs Made In America Acquisition II's quarterly Total Liabilities declined from Sep. 2025 ($18.18 Mil) to Dec. 2025 ($17.80 Mil) but then increased from Dec. 2025 ($17.80 Mil) to Mar. 2026 ($18.17 Mil).

Drugs Made In America Acquisition II's annual Total Liabilities increased from . 20 ($0.00 Mil) to Dec. 2024 ($0.26 Mil) and increased from Dec. 2024 ($0.26 Mil) to Dec. 2025 ($17.80 Mil).


Drugs Made In America Acquisition II Total Liabilities Historical Data

* Premium members only.

The historical data trend for Drugs Made In America Acquisition II's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Drugs Made In America Acquisition II Total Liabilities Chart

Drugs Made In America Acquisition II Annual Data
Trend Dec24 Dec25
Total Liabilities
0.26 17.80

Drugs Made In America Acquisition II Quarterly Data
Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial 0.28 0.33 18.18 17.80 18.17
DMII
15GF Score
Drugs Made In America Acquisition II Corp DMII
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Drugs Made In America Acquisition II Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Drugs Made In America Acquisition II's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=504.96-487.159
=17.80

Drugs Made In America Acquisition II's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=509.725-491.559
=18.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $18.17 Mil mean?
Drugs Made In America Acquisition II (DMII) has a Total Liabilities of $18.17 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Drugs Made In America Acquisition II and its competitors.
Is Drugs Made In America Acquisition II's Total Liabilities too high?
Drugs Made In America Acquisition II's current Total Liabilities is $18.17 Mil. Overall, Drugs Made In America Acquisition II has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Drugs Made In America Acquisition II's Total Liabilities compare to BCSS and EVAC?
Drugs Made In America Acquisition II's Total Liabilities of $18.17 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Diversified Financial Services company?
A good Total Liabilities depends on the Diversified Financial Services industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Drugs Made In America Acquisition II and its competitors. Drugs Made In America Acquisition II's current Total Liabilities is $18.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drugs Made In America Acquisition II stock overvalued right now?
Drugs Made In America Acquisition II (DMII) has a current Total Liabilities of $18.17 Mil. The current Total Liabilities is $18.17 Mil. Drugs Made In America Acquisition II's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Drugs Made In America Acquisition II (DMII), the current Total Liabilities is $18.17 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Drugs Made In America Acquisition II Business Description

Address 420 Lexington Avenue, Suite 1402, New York, NY, USA, 10170
Drugs Made In America Acquisition II Corp is a blank check Company.
15GF Score

Get the complete analysis for DMII

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.10
Price